Zhengye Biotechnology Holding Ltd
NASDAQ:ZYBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhengye Biotechnology Holding Ltd
NASDAQ:ZYBT
|
CN |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
N
|
Nokia Oyj
XBER:NOA3
|
FI |
|
Lanxess AG
OTC:LNXSY
|
DE |
|
A
|
Aeroports de Paris SA
SWB:W7L
|
FR |
|
B
|
Bermaz Auto Bhd
KLSE:BAUTO
|
MY |
|
N
|
Nampak Ltd
XBER:NNZA
|
ZA |
|
Burford Capital Ltd
NYSE:BUR
|
GG |
|
B
|
Bureau Veritas SA
DUS:4BV
|
FR |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
Onto Innovation Inc
NYSE:ONTO
|
US |
|
Ariana Resources PLC
LSE:AAU
|
UK |
|
A
|
Australian Vanadium Ltd
F:JT71
|
AU |
|
S
|
Sumitomo Corp
F:SUMB
|
JP |
|
D
|
Diversified Royalty Corp
F:BEW
|
CA |
|
S
|
Sherwin-Williams Co
F:SJ3
|
US |
Bankruptcy Probability
Zhengye Biotechnology Holding Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zhengye Biotechnology Holding Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Zhengye Biotechnology Holding Ltd
NASDAQ:ZYBT
|
36.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
639.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
321.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
246.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
203.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
194.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zhengye Biotechnology Holding Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zhengye Biotechnology Holding Ltd has total debt of 8.9m CNY. This includes both short-term (0 CNY) and long-term (8.9m CNY) debt.
You can find a full breakdown on its Balance Sheet.
